Edwards Lifesciences was incorporated in Delaware in 1999.
Edwards Lifesciences has more than 9,000 employees worldwide.
Edwards Lifesciences' headquarters are located in Irvine, California. The company has sales and manufacturing offices located throughout the world.
Edwards Lifesciences' facilities are primarily used for business purposes only and are not open to the public. Each year, we welcome all of our shareholders to the Annual Meeting of Stockholders which is typically held at our Irvine facility. Notice of the meeting, which is usually held in May, is included in the company's proxy statement.
We believe we are one of the leading competitors, in terms of global market share, in each of our major product lines. Our products and technologies face substantial competition from a number of companies including divisions of companies much larger than Edwards Lifesciences and smaller companies that compete in specific product categories or certain geographies. In Surgical and Transcatheter Heart Valve therapies, our primary competitors include St. Jude Medical, Inc., Medtronic, Inc. and Sorin Group. In Critical Care, we compete primarily with a variety of companies in specific product categories including ICU Medical, Inc., PULSION Medical Systems AG and LiDCO Group PLC.
Please submit your question using the form below.
David K. Erickson
Vice President, Investor Relations
phone: (949) 250-6826
Sr. Manager, Investor Relations
phone: (949) 250-2752